Ok it's an infomercial but a well presented piece, far and away the most stylish promotional material PAA has managed thus far.
Dr Aston comes across well. Making explicit that we're dealing with a new class of drug and the potential of the mTOR pathway should generate some interest.
Time frames for phase 2 human and next stage canine trials will help particularly if a trial partner in the US can be established.
PharmAust: Developing Targeted Cancer Therapy, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.51M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.3¢ | 17.5¢ | $205.5K | 1.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55777 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 56756 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |